Clinical trial
Estratificação de Risco em Cirurgia de revascularização miocárdica no Brasil: CABG - BraSCORE (Brazilian System for Cardiac Operative Risk Evaluation)
NCT07293533 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Estratificação de Risco em Cirurgia de revascularização miocárdica no Brasil: CABG - BraSCORE (Brazilian System for Cardiac Operative Risk Evaluation)
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- April 1, 2024
- Completion date
- July 30, 2026
- Enrollment
- 2,400 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
cabg-patients